menu-control
The Jerusalem Post

Clinical Trial
- Participation Opportunity for Erectile Dysfunction

 
  (photo credit: Ohh-Med Medical)
(photo credit: Ohh-Med Medical)

The Condition

Erectile Dysfunction is a common condition affecting over 18 million men in the US, impacting their ability to achieve or maintain sufficient firmness for intimate activity.* This condition can lead to physical and emotional challenges, affecting relationships and overall quality of life. Despite its prevalence, effective and accessible non-invasive treatment options remain limited, highlighting the need for further research and innovation in this area.

  (credit: Ohh-Med Medical)
(credit: Ohh-Med Medical)

About the Study

This clinical trial aims to assess the safety and effectiveness of the investigational VERTICA device. The VERTICA device is designed for home use, delivering low-intensity radiofrequency (LI-RF) energy to the penile area. This targeted RF energy therapeutically raises penile tissue temperature, leading to improved muscular and vascular condition and erectile function.

Currently, there are few device options available for clinicians to treat ED non-invasively. This study will contribute valuable data on the safety and potential efficacy of the VERTICA device as a treatment option.

Advertisement

  (credit: Ohh-Med Medical)
(credit: Ohh-Med Medical)

Contact Information

If you are located in San Diego, Houston, Miami, or Cleveland and are interested in participating, please contact tali@asteinrac.com (CRO).

Further details are also available at www.ohhmed.com

*Source: Johns Hopkins Bloomberg School of Public Health

This article was written in cooperation with Ohh-Med Medical

×
Email:
×
Email: